These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29326935)

  • 1. Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.
    Moor CC; Heukels P; Kool M; Wijsenbeek MS
    Front Med (Lausanne); 2017; 4():226. PubMed ID: 29326935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.
    Swigris JJ; Stewart AL; Gould MK; Wilson SR
    Health Qual Life Outcomes; 2005 Oct; 3():61. PubMed ID: 16212668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction.
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2024 Jun; 2(2):72-79. PubMed ID: 38962100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing quality of life in patients with idiopathic pulmonary fibrosis.
    van Manen MJ; Geelhoed JJ; Tak NC; Wijsenbeek MS
    Ther Adv Respir Dis; 2017 Mar; 11(3):157-169. PubMed ID: 28134007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Herth FJF; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Frankenberger M; Behr J
    Respir Res; 2017 Jul; 18(1):139. PubMed ID: 28709421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary fibrosis: exploring the clinical and economic implications of the evolving treatment landscape.
    de Andrade JA; Owens GM; Tolle L
    Am J Manag Care; 2021 May; 27(7 Suppl):S131-S137. PubMed ID: 34003616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines.
    Sharif R
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S176-S182. PubMed ID: 28978212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
    Singh V; Ulasov I; Gupta S; Singh A; Roy VK; Kharwar RK
    Discov Med; 2024 Jan; 36(180):22-47. PubMed ID: 38273744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.
    Oldham JM; Collard HR
    Front Med (Lausanne); 2017; 4():123. PubMed ID: 28824912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review.
    Ding D; Gao R; Xue Q; Luan R; Yang J
    Int J Med Sci; 2023; 20(3):329-345. PubMed ID: 36860670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis.
    Koudstaal T; Wijsenbeek MS
    Presse Med; 2023 Sep; 52(3):104166. PubMed ID: 37156412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis: only PROMises?
    Wijsenbeek M; van Manen M; Bonella F
    Curr Opin Pulm Med; 2016 Sep; 22(5):434-41. PubMed ID: 27333428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and management of idiopathic pulmonary fibrosis.
    Quinn C; Wisse A; Manns ST
    Multidiscip Respir Med; 2019; 14():35. PubMed ID: 31827795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis.
    Tzouvelekis A; Herazo-Maya J; Sakamoto K; Bouros D
    Curr Top Med Chem; 2016; 16(14):1587-98. PubMed ID: 26420365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of idiopathic pulmonary fibrosis on patients' emotional well being and quality of life: a literature review.
    Antoniou K; Kamekis A; Symvoulakis EK; Kokosi M; Swigris JJ
    Curr Opin Pulm Med; 2020 Sep; 26(5):457-463. PubMed ID: 32701673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.
    Spagnolo P; Cottin V
    J Med Genet; 2017 Feb; 54(2):93-99. PubMed ID: 28011761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Idiopathic Pulmonary Fibrosis.
    Pleasants R; Tighe RM
    Ann Pharmacother; 2019 Dec; 53(12):1238-1248. PubMed ID: 31280590
    [No Abstract]   [Full Text] [Related]  

  • 18. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue.
    Caminati A; Lonati C; Cassandro R; Elia D; Pelosi G; Torre O; Zompatori M; Uslenghi E; Harari S
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31578211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets in idiopathic pulmonary fibrosis.
    Kolb M; Bonella F; Wollin L
    Respir Med; 2017 Oct; 131():49-57. PubMed ID: 28947042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.